AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

AMOXICIILLINE

11 registrations across 1 African market— 11 active

Markets with AMOXICIILLINE

Recent registrations

Brand / ProductMarketHolderStatusExpires
AMOXICILLINE SANDOZ
comprimé pelliculé / 1000 mg
🇸🇳SenegalSANDOZactive
PHARMOX
comprimé / 500 mg
🇸🇳SenegalPHARMA 5active
AMOXICILLINE
gélule / 500 mg
🇸🇳SenegalMEDISactive
SERVAMOX
suspension buvable / 125 mg
🇸🇳SenegalSERVIPHARMactive
AMODEX
poudre suspension buvable / 250 mg
🇸🇳SenegalSYNTHELABOactive
ZAMOCILLINE
gélule / 500 mg
🇸🇳SenegalZAMBON FRANCEactive
AMOXICILLINE CREAT
gélule / 500 mg
🇸🇳SenegalBAILLY- CREATactive
SERVAMOX
gélule / 500 mg
🇸🇳SenegalSERVIPHARMactive
SERVAMOX
gélule / 250 mg
🇸🇳SenegalSERVIPHARMactive
AMOXICILLINE TYROL PHARMA
gélule / 500 mg
🇸🇳SenegalBIOCHEMIEactive
AMOKOD
gélule / 500 mg
🇸🇳SenegalRHONE POULENC RORERactive

AMOXICIILLINE in Africa — Regulatory Overview

AMOXICIILLINE is registered across 1 African markets with 11 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Senegal. AfricaRegulatory refreshes this data daily from official government sources.

Of the 11 registrations, 11 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.